| Market Capitalization (Millions $) |
1,982 |
| Shares
Outstanding (Millions) |
18 |
| Employees |
202 |
| Revenues (TTM) (Millions $) |
167 |
| Net Income (TTM) (Millions $) |
-4 |
| Cash Flow (TTM) (Millions $) |
49 |
| Capital Exp. (TTM) (Millions $) |
2 |
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc. is a biopharmaceutical company that was founded in 1987 and is based in San Diego, California. The company's primary focus is on developing innovative medicines to treat serious diseases, and it has a diversified portfolio of drugs in various stages of development.
Ligand's primary area of expertise is in developing small molecule drugs that can selectively target specific cellular pathways to treat diseases. The company's technology platform is based on its proprietary Captisole technology, which is a drug delivery technology that improves the solubility and bioavailability of drugs. This technology has been licensed to various pharmaceutical companies for the development of their own drugs.
The company has a broad portfolio of drugs that are either in clinical trials or have been approved by regulatory agencies. Ligand's current portfolio includes drugs for the treatment of cancer, inflammatory diseases, metabolic disorders, and other diseases. Some of the drugs in the company's portfolio include Promactae (eltrombopag), Amgen's Omecamtiv Mecarbil (a cardiac muscle activator), and Evomelae (melphalan hydrochloride), among others.
Ligand has a business model that involves licensing its technology and intellectual property to pharmaceutical companies for the development of their own drugs. This allows the company to generate royalties and other revenue streams from these partnerships. It also allows the company to diversify its pipeline and reduce its reliance on any individual drug or therapeutic area.
The company has received numerous awards and recognitions for its innovative technology and drug development programs. In 2020, Ligand was named to Forbes America's Best Small Companies list, and its Captisole technology was named one of R&D Magazine's 100 most significant innovations of the year.
Overall, Ligand Pharmaceuticals Inc. is a leading biopharmaceutical company that is focused on developing innovative drugs to treat serious diseases. The company's technology platform and diversified pipeline make it a strong candidate for continued growth and success in the biotech industry.
Company Address: 555 Heritage Drive, Suite 200 Jupiter 33458 FL
Company Phone Number: 550-7500 Stock Exchange / Ticker: NASDAQ LGND
|
1.92% 